Cargando…
Cell Origins of High-Grade Serous Ovarian Cancer
High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is the most common and deadliest type of ovarian cancer. HGSC appears to arise from the ovary, fallopian tube, or peritoneum. As most HGSC cases present with widespread peritoneal metastases, it is often not clear wh...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267333/ https://www.ncbi.nlm.nih.gov/pubmed/30424539 http://dx.doi.org/10.3390/cancers10110433 |
_version_ | 1783376043475730432 |
---|---|
author | Kim, Jaeyeon Park, Eun Young Kim, Olga Schilder, Jeanne M. Coffey, Donna M. Cho, Chi-Heum Bast, Robert C. |
author_facet | Kim, Jaeyeon Park, Eun Young Kim, Olga Schilder, Jeanne M. Coffey, Donna M. Cho, Chi-Heum Bast, Robert C. |
author_sort | Kim, Jaeyeon |
collection | PubMed |
description | High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is the most common and deadliest type of ovarian cancer. HGSC appears to arise from the ovary, fallopian tube, or peritoneum. As most HGSC cases present with widespread peritoneal metastases, it is often not clear where HGSC truly originates. Traditionally, the ovarian surface epithelium (OSE) was long believed to be the origin of HGSC. Since the late 1990s, the fallopian tube epithelium has emerged as a potential primary origin of HGSC. Particularly, serous tubal intraepithelial carcinoma (STIC), a noninvasive tumor lesion formed preferentially in the distal fallopian tube epithelium, was proposed as a precursor for HGSC. It was hypothesized that STIC lesions would progress, over time, to malignant and metastatic HGSC, arising from the fallopian tube or after implanting on the ovary or peritoneum. Many clinical studies and several mouse models support the fallopian tube STIC origin of HGSC. Current evidence indicates that STIC may serve as a precursor for HGSC in high-risk women carrying germline BRCA1 or 2 mutations. Yet not all STIC lesions appear to progress to clinical HGSCs, nor would all HGSCs arise from STIC lesions, even in high-risk women. Moreover, the clinical importance of STIC remains less clear in women in the general population, in which 85–90% of all HGSCs arise. Recently, increasing attention has been brought to the possibility that many potential precursor or premalignant lesions, though composed of microscopically—and genetically—cancerous cells, do not advance to malignant tumors or lethal malignancies. Hence, rigorous causal evidence would be crucial to establish that STIC is a bona fide premalignant lesion for metastatic HGSC. While not all STICs may transform into malignant tumors, these lesions are clearly associated with increased risk for HGSC. Identification of the molecular characteristics of STICs that predict their malignant potential and clinical behavior would bolster the clinical importance of STIC. Also, as STIC lesions alone cannot account for all HGSCs, other potential cellular origins of HGSC need to be investigated. The fallopian tube stroma in mice, for instance, has been shown to be capable of giving rise to metastatic HGSC, which faithfully recapitulates the clinical behavior and molecular aspect of human HGSC. Elucidating the precise cell(s) of origin of HGSC will be critical for improving the early detection and prevention of ovarian cancer, ultimately reducing ovarian cancer mortality. |
format | Online Article Text |
id | pubmed-6267333 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62673332018-12-03 Cell Origins of High-Grade Serous Ovarian Cancer Kim, Jaeyeon Park, Eun Young Kim, Olga Schilder, Jeanne M. Coffey, Donna M. Cho, Chi-Heum Bast, Robert C. Cancers (Basel) Review High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is the most common and deadliest type of ovarian cancer. HGSC appears to arise from the ovary, fallopian tube, or peritoneum. As most HGSC cases present with widespread peritoneal metastases, it is often not clear where HGSC truly originates. Traditionally, the ovarian surface epithelium (OSE) was long believed to be the origin of HGSC. Since the late 1990s, the fallopian tube epithelium has emerged as a potential primary origin of HGSC. Particularly, serous tubal intraepithelial carcinoma (STIC), a noninvasive tumor lesion formed preferentially in the distal fallopian tube epithelium, was proposed as a precursor for HGSC. It was hypothesized that STIC lesions would progress, over time, to malignant and metastatic HGSC, arising from the fallopian tube or after implanting on the ovary or peritoneum. Many clinical studies and several mouse models support the fallopian tube STIC origin of HGSC. Current evidence indicates that STIC may serve as a precursor for HGSC in high-risk women carrying germline BRCA1 or 2 mutations. Yet not all STIC lesions appear to progress to clinical HGSCs, nor would all HGSCs arise from STIC lesions, even in high-risk women. Moreover, the clinical importance of STIC remains less clear in women in the general population, in which 85–90% of all HGSCs arise. Recently, increasing attention has been brought to the possibility that many potential precursor or premalignant lesions, though composed of microscopically—and genetically—cancerous cells, do not advance to malignant tumors or lethal malignancies. Hence, rigorous causal evidence would be crucial to establish that STIC is a bona fide premalignant lesion for metastatic HGSC. While not all STICs may transform into malignant tumors, these lesions are clearly associated with increased risk for HGSC. Identification of the molecular characteristics of STICs that predict their malignant potential and clinical behavior would bolster the clinical importance of STIC. Also, as STIC lesions alone cannot account for all HGSCs, other potential cellular origins of HGSC need to be investigated. The fallopian tube stroma in mice, for instance, has been shown to be capable of giving rise to metastatic HGSC, which faithfully recapitulates the clinical behavior and molecular aspect of human HGSC. Elucidating the precise cell(s) of origin of HGSC will be critical for improving the early detection and prevention of ovarian cancer, ultimately reducing ovarian cancer mortality. MDPI 2018-11-12 /pmc/articles/PMC6267333/ /pubmed/30424539 http://dx.doi.org/10.3390/cancers10110433 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kim, Jaeyeon Park, Eun Young Kim, Olga Schilder, Jeanne M. Coffey, Donna M. Cho, Chi-Heum Bast, Robert C. Cell Origins of High-Grade Serous Ovarian Cancer |
title | Cell Origins of High-Grade Serous Ovarian Cancer |
title_full | Cell Origins of High-Grade Serous Ovarian Cancer |
title_fullStr | Cell Origins of High-Grade Serous Ovarian Cancer |
title_full_unstemmed | Cell Origins of High-Grade Serous Ovarian Cancer |
title_short | Cell Origins of High-Grade Serous Ovarian Cancer |
title_sort | cell origins of high-grade serous ovarian cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267333/ https://www.ncbi.nlm.nih.gov/pubmed/30424539 http://dx.doi.org/10.3390/cancers10110433 |
work_keys_str_mv | AT kimjaeyeon celloriginsofhighgradeserousovariancancer AT parkeunyoung celloriginsofhighgradeserousovariancancer AT kimolga celloriginsofhighgradeserousovariancancer AT schilderjeannem celloriginsofhighgradeserousovariancancer AT coffeydonnam celloriginsofhighgradeserousovariancancer AT chochiheum celloriginsofhighgradeserousovariancancer AT bastrobertc celloriginsofhighgradeserousovariancancer |